IMU has been one of the worst performing Biotechs on the ASX.
94 % drop in SP value, spin that how you like.
Them’s the facts.
Ann: Imugene Confirms Pending Receipt of c.$11m R&D Tax Refund, page-165
Add to My Watchlist
What is My Watchlist?